Is it time to buy Ansell?

Could the recent US$615 million acquisition by Ansell be a game changer?

a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Protective health and safety manufacturer Ansell (ASX: ANN), has announced the acquisition of BarrierSafe Solutions; a leading North American provider of single-use gloves for a total consideration is US$615 million.

BarrierSafe which has sales of approximately US$290 million per annum, was described by Ansell, as an acquisition which would "further expand its position in the hand protection market in North America and continues to implement its strategy to create shareholder value through organic and acquisition driven growth."

To fund the acquisition – which was priced at 9.7 times enterprise value to earnings before interest, tax, depreciation and amortisation (EV/EBITDA) – Ansell is conducting a fully-underwritten equity raising for US$308 million and share purchase plan (SPP) to raise a further US$91 million.

What the acquisition means for investors

Ansell expects significant cost synergies from both supply chain savings and increased cross-selling and vertical development. Management provided guidance that on a normalised basis, they expect the BarrierSafe acquisition to be accretive to earnings per share (EPS) in the low-single digit percentages in financial year (FY) 2014 and in the mid-single digit percentages in FY 2015.

Foolish takeaway

While Ansell trades on a trailing price-to-earnings ratio (PE) of 18.5, this is not particularly expensive considering the company's impressive track record. Not only have there been 20 successive dividend increases over the past 10 years but Ansell has also delivered shareholders 10 years of EPS growth.

The size of the BarrierSafe acquisition is undoubtedly material to Ansell and should allow the company to continue its growth trajectory and also expand its presence in the US market and increase its exposure to US dollar denominated earnings.

As investors in businesses with leading positions in the USA – such as Brambles (ASX: BXB) and CSL (ASX: CSL) – are aware, the benefits of exposure to these markets in terms of growth potential can be highly desirable. BarrierSafe looks like an appealing investment for Ansell and shareholders should probably consider taking up their SPP entitlements.

Motley Fool contributor Tim McArthur does not own shares in any of the companies mentioned in this article.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »